IMCURE THERAPEUTICS
Similar Organizations
Adriacell
Anti-tumor therapeutics
Pathfinder Therapeutics
Pathfinder Therapeutics
Senexta Therapeutics
Senexta Therapeutics
More informations about "ImCure Therapeutics"
ImCure Therapeutics - Crunchbase Company Profile & Funding
Who are ImCure Therapeutics 's competitors? Alternatives and possible competitors to ImCure Therapeutics may include Diorasis Therapeutics , Pathfinder Therapeutics , and Solaris โฆSee details»
ImCure Therapeutics 2025 Company Profile: Valuation, โฆ
ImCure Therapeutics General Information Description. Developer of cardiovascular and arthritis treatments. The company develops drugs and other water-soluble cholesterol altering compounds for treating cardiovascular and โฆSee details»
Imcure Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore Imcure Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Drug:184045 (Imcure Therapeutics, Inc.).See details»
Joseph Rubinfeld Ph.D Profile: Contact Information & Network
May 30, 1997 Dr. Joseph Rubinfeld is the Founder of ImCure Therapeutics. He served as Independent Director at International Infusion. He is the Founder of JJ Pharma. He served as โฆSee details»
Imcure Therapeutics, Inc.:Company Profile & Technical Research ...
Oct 27, 2022 Imcure Therapeutics Inc is headquartered in US CA. Imcure Therapeutics Inc was founded in 2003. Imcure Therapeutics Inc has a total of 15 patents . Related Topics. โฆSee details»
184045 (Imcure Therapeutics, Inc.) - Drug Targets, Indications, โฆ
100 Translational Medicine associated with 184045 (Imcure Therapeutics, Inc.) Login to view more data 100 Patents (Medical) associated with 184045 (Imcure Therapeutics, Inc.)See details»
IMCURE THERAPEUTICS, INC. :: California (US) - OpenCorporates
IMCURE THERAPEUTICS, INC. Company Number 2569549 Previous Company Numbers. C2569549; Status Suspended Ftb/Sos Incorporation Date 18 December 2003 (about 19 years โฆSee details»
Imcure Therapeutics, Inc. in San Francisco CA - Company Profile
Imcure Therapeutics, Inc. Overview. Imcure Therapeutics, Inc. filed as an Articles of Incorporation in the State of California and is no longer active.This corporate entity was filed approximately โฆSee details»
Imcure Therapeutics, Inc.:Patent,Patent Application,Portfolio โฆ
Discovery Company profile page for Imcure Therapeutics, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
ImCure Therapeutics (ImCure Therapeutics) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ โฆ
ไบ่งฃImCure Therapeutics (ImCure Therapeutics)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็ใSee details»
InnoCure Therapeutics 2025 Company Profile: โฆ
InnoCure Therapeutics General Information Description. Developer of biopharmaceuticals dedicated to the discovery and development of novel drugs. The company's next-generation protein degradation mechanisms are โฆSee details»
GeneSegues Therapeutics - Crunchbase Company Profile & Funding
Alternatives and possible competitors to GeneSegues Therapeutics may include Diorasis Therapeutics, Genex Space, and ImCure Therapeutics. Browse By: Organizations, People, โฆSee details»
Emcure Pharmaceuticals - Crunchbase Company Profile & Funding
Emcure was born out of the vision to create a healthcare company that would address the vast healthcare needs. They commitment and drive have propelled our growth from a single โฆSee details»
Orgenesis and Cure Therapeutics Form Joint Venture for Cell
On Dec. 9, 2020, Orgenesis, a global biotech company focused on cell and gene therapies, and Cure Therapeutics, a developer of immuno-oncology and cell and gene therapies, announced โฆSee details»
Imfinzi approved in the US as first and only perioperative ...
Mar 31, 2025 Notes. Muscle-invasive bladder cancer Bladder cancer is the 9th most common cancer in the world, with more than 614,000 patients diagnosed each year. 5 The most โฆSee details»
Development of an Innovative Treatment for Parkinson's
23 hours ago /CNW/ - Sylvain Chrétien, CEO and cofounder of Canadian biotech firm Synucure Therapeutics, ... Organization Profile. Synucure Therapeutics Inc. Contact Cision. 866-245-2317See details»
Emcure Pharmaceuticals: Founder | IPO | Subsidiaries - StartupTalky
Jul 12, 2024 Emcure's pipeline of innovative pharmaceuticals and unique biologics portfolio support the company's innovative business model. The organization hopes to maintain its โฆSee details»
DeepCure
DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure โฆSee details»
Emcure Pharmaceuticals | Leading Global Pharmaceutical Company
Aug 5, 2021 Emcure Pharmaceuticals Limited was built with the purpose and core belief of making E ffective M edicines to Cure patients enabling them to lead healthier lives. We are a โฆSee details»
Emcure Pharma IPO: All you need to know - Value Research
Jul 2, 2024 It is the market leader in the gynaecology and HIV antiviral therapeutics, and is among the top 10 players in five other therapeutic areas in terms of market share. Vertical โฆSee details»